Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0002034671-25-000012

Chief Executive Officer acquired 29,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mazumdar Claire Chief Executive Officer 2025-12-16 Option exercise +29,500 $5.45 $160,884 339,392 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mazumdar Claire Chief Executive Officer 2025-12-16 Option exercise · Stock Option (Right to Buy) −29,500 565,512 D: show line 2 in the form
Loading xslF345X05/wk-form4_1766098974.xml…